Research & Development
29 June 2022 - - US-based gene therapy company SwanBio Therapeutics presented details about the company's ongoing natural history study of adrenomyeloneuropathy at the 8th Congress of the Eu...
29 June 2022 - - The first two patients have been dosed in US-based clinical-stage microbiome company BiomX Inc's (NYSE American: PHGE) Phase 1b/2a study evaluating BX004 for the treatment of chr...
29 June 2022 - - The US Food and Drug Administration has approved the Phase 1/2a clinical trial of Singapore-based biopharmaceutical company Prestige Biopharma Ltd's first-in-class anti-PAUF mono...
29 June 2022 - Glenmark Pharmaceuticals Ltd., an India-based, global pharmaceutical company, announced on Tuesday that Glenmark Pharmaceuticals Inc., USA, a fully owned subsidiary of Glenmark Pharmace...
29 June 2022 - Soligenix, Inc. (Nasdaq: SNGX), a US-based late-stage biopharmaceutical company, announced on Tuesday that it has received approval from the United States Food and Drug Administration (...
28 June 2022 - - The Food and Drug Administration has placed a partial clinical hold on US-based biopharmaceutical company Nuvation Bio Inc's (NYSE: NUVB) Phase 1 dose escalation study of NUV-422...
Related Headlines